Filing Summary
Business Context and Reporting Period
Journey Medical Corporation filed a Form 8-K regarding a management appointment. The report date and earliest event date were April 26, 2024; the filing was signed on May 1, 2024. The company’s common stock trades on the Nasdaq Capital Market under the symbol DERM.
Financial Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial metrics.
Material Changes
- On April 26, 2024, the board appointed Joseph Benesch as the company’s permanent Chief Financial Officer.
- Mr. Benesch had served as interim CFO since January 27, 2023.
- His compensation did not change as a result of the appointment. Any future changes will be determined by the board upon recommendation of the Compensation Committee.
- The filing states that Mr. Benesch has no family relationships with the company’s directors or other executive officers, no undisclosed selection arrangements, and no reportable related-party transaction under Item 404(a) of Regulation S-K.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance, business outlook, risk updates, contingencies, or unusual financial items. Exhibit 99.1 is a press release dated May 1, 2024 announcing the CFO appointment.
Key Facts to Verify
- Confirm the effective date and permanence of Mr. Benesch’s CFO appointment.
- Review Exhibit 99.1 for any additional biographical or management commentary.
- Verify any subsequent changes to Mr. Benesch’s compensation package.
- Note the timing discrepancy between the April 26 report and earliest event date and the May 1 press release and filing signature date.